vs
Side-by-side financial comparison of OLIN Corp (OLN) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
OLIN Corp is the larger business by last-quarter revenue ($1.7B vs $1.4B, roughly 1.2× SELECT MEDICAL HOLDINGS CORP). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 4.5% vs -8.6%, a 13.1% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (5.0% vs -0.4%). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (5.3% CAGR vs 0.9%).
Olin Corporation is an American manufacturer of ammunition, chlorine, and sodium hydroxide. The company traces its roots to two companies, both founded in 1892: Franklin W. Olin's Equitable Powder Company and the Mathieson Alkali Works. Accidents at Olin chemical plants have exposed employees and nearby residents to health hazards.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
OLN vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.4B |
| Net Profit | $-143.2M | $63.8M |
| Gross Margin | 1.9% | — |
| Operating Margin | -9.4% | 6.9% |
| Net Margin | -8.6% | 4.5% |
| Revenue YoY | -0.4% | 5.0% |
| Net Profit YoY | -1517.8% | -14.7% |
| EPS (diluted) | $-1.25 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.8B | $1.3B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.6B | $1.3B | ||
| Q2 24 | $1.6B | $1.3B |
| Q1 26 | — | $63.8M | ||
| Q4 25 | $-143.2M | $20.2M | ||
| Q3 25 | $43.7M | $28.8M | ||
| Q2 25 | $-2.8M | $40.6M | ||
| Q1 25 | $1.2M | $56.7M | ||
| Q4 24 | $10.1M | $-16.1M | ||
| Q3 24 | $-25.2M | $55.6M | ||
| Q2 24 | $72.3M | $77.6M |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 7.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 9.4% | — | ||
| Q3 24 | 8.5% | — | ||
| Q2 24 | 14.5% | — |
| Q1 26 | — | 6.9% | ||
| Q4 25 | -9.4% | 4.6% | ||
| Q3 25 | 4.8% | 5.4% | ||
| Q2 25 | 2.0% | 6.5% | ||
| Q1 25 | 2.7% | 8.3% | ||
| Q4 24 | 2.8% | 1.6% | ||
| Q3 24 | 1.0% | 4.3% | ||
| Q2 24 | 8.3% | 5.8% |
| Q1 26 | — | 4.5% | ||
| Q4 25 | -8.6% | 1.4% | ||
| Q3 25 | 2.6% | 2.1% | ||
| Q2 25 | -0.2% | 3.0% | ||
| Q1 25 | 0.1% | 4.2% | ||
| Q4 24 | 0.6% | -1.2% | ||
| Q3 24 | -1.6% | 4.4% | ||
| Q2 24 | 4.4% | 6.1% |
| Q1 26 | — | $0.35 | ||
| Q4 25 | $-1.25 | $0.17 | ||
| Q3 25 | $0.37 | $0.23 | ||
| Q2 25 | $-0.01 | $0.32 | ||
| Q1 25 | $0.01 | $0.44 | ||
| Q4 24 | $0.10 | $-0.12 | ||
| Q3 24 | $-0.21 | $0.43 | ||
| Q2 24 | $0.62 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $25.7M |
| Total DebtLower is stronger | $2.8B | $1.8B |
| Stockholders' EquityBook value | $1.8B | $2.1B |
| Total Assets | $7.3B | $6.0B |
| Debt / EquityLower = less leverage | 1.55× | 0.88× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $25.7M | ||
| Q4 25 | $167.6M | $26.5M | ||
| Q3 25 | — | $60.1M | ||
| Q2 25 | — | $52.3M | ||
| Q1 25 | — | $53.2M | ||
| Q4 24 | $175.6M | $59.7M | ||
| Q3 24 | — | $191.5M | ||
| Q2 24 | — | $111.2M |
| Q1 26 | — | $1.8B | ||
| Q4 25 | $2.8B | $1.8B | ||
| Q3 25 | $3.0B | $1.7B | ||
| Q2 25 | $3.0B | $1.8B | ||
| Q1 25 | $3.0B | $1.8B | ||
| Q4 24 | $2.7B | $1.7B | ||
| Q3 24 | $2.8B | $3.1B | ||
| Q2 24 | $2.8B | $3.6B |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.8B | $1.7B | ||
| Q3 25 | $2.0B | $1.7B | ||
| Q2 25 | $2.0B | $1.7B | ||
| Q1 25 | $2.0B | $1.7B | ||
| Q4 24 | $2.0B | $1.7B | ||
| Q3 24 | $2.1B | $1.9B | ||
| Q2 24 | $2.1B | $1.4B |
| Q1 26 | — | $6.0B | ||
| Q4 25 | $7.3B | $5.9B | ||
| Q3 25 | $7.6B | $5.7B | ||
| Q2 25 | $7.7B | $5.7B | ||
| Q1 25 | $7.7B | $5.7B | ||
| Q4 24 | $7.6B | $5.6B | ||
| Q3 24 | $7.5B | $8.0B | ||
| Q2 24 | $7.7B | $7.9B |
| Q1 26 | — | 0.88× | ||
| Q4 25 | 1.55× | 1.06× | ||
| Q3 25 | 1.52× | 1.03× | ||
| Q2 25 | 1.52× | 1.10× | ||
| Q1 25 | 1.50× | 1.03× | ||
| Q4 24 | 1.34× | 1.01× | ||
| Q3 24 | 1.34× | 1.62× | ||
| Q2 24 | 1.31× | 2.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $321.2M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $321.2M | $64.3M | ||
| Q3 25 | $26.7M | $175.3M | ||
| Q2 25 | $212.3M | $110.3M | ||
| Q1 25 | $-86.0M | $-3.5M | ||
| Q4 24 | $141.7M | $125.4M | ||
| Q3 24 | $189.9M | $181.0M | ||
| Q2 24 | $90.6M | $278.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $5.2M | ||
| Q3 25 | $-44.4M | $122.2M | ||
| Q2 25 | — | $45.6M | ||
| Q1 25 | $-147.4M | $-55.8M | ||
| Q4 24 | $90.7M | $62.0M | ||
| Q3 24 | $146.6M | $130.3M | ||
| Q2 24 | $34.1M | $222.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.4% | ||
| Q3 25 | -2.6% | 9.0% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | -9.0% | -4.1% | ||
| Q4 24 | 5.4% | 4.7% | ||
| Q3 24 | 9.2% | 10.2% | ||
| Q2 24 | 2.1% | 17.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.2% | ||
| Q3 25 | 4.2% | 3.9% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | 3.7% | 3.9% | ||
| Q4 24 | 3.1% | 4.8% | ||
| Q3 24 | 2.7% | 4.0% | ||
| Q2 24 | 3.4% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.19× | ||
| Q3 25 | 0.61× | 6.09× | ||
| Q2 25 | — | 2.72× | ||
| Q1 25 | -71.67× | -0.06× | ||
| Q4 24 | 14.03× | — | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | 1.25× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OLN
| Chlorinechlorinederivativesandothercoproducts | $456.2M | 27% |
| Causticsoda | $400.2M | 24% |
| Militaryandlawenforcement | $304.6M | 18% |
| Epoxyresins | $194.9M | 12% |
| Aromaticsandallylics | $164.4M | 10% |
| Commercial | $144.8M | 9% |
SEM
Segment breakdown not available.
